Suppr超能文献

SARS-CoV-2 刺突进化行为;模拟 N501Y 突变在免疫原性和结构特征方面的结果。

SARS-CoV-2 spike evolutionary behaviors; simulation of N501Y mutation outcomes in terms of immunogenicity and structural characteristic.

机构信息

Department of Chemical Engineering, Faculty of Engineering, Arak University, Arak, Iran.

Department of Medical Biotechnology, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.

出版信息

J Cell Biochem. 2022 Feb;123(2):417-430. doi: 10.1002/jcb.30181. Epub 2021 Nov 15.

Abstract

Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a large number of mutations in its genome have been reported. Some of the mutations occur in noncoding regions without affecting the pathobiology of the virus, while mutations in coding regions are significant. One of the regions where a mutation can occur, affecting the function of the virus is at the receptor-binding domain (RBD) of the spike protein. RBD interacts with angiotensin-converting enzyme 2 (ACE2) and facilitates the entry of the virus into the host cells. There is a lot of focus on RBD mutations, especially the displacement of N501Y which is observed in the UK/Kent, South Africa, and Brazilian lineages of SARS-CoV-2. Our group utilizes computational biology approaches such as immunoinformatics, protein-protein interaction analysis, molecular dynamics, free energy computation, and tertiary structure analysis to disclose the consequences of N501Y mutation at the molecular level. Surprisingly, we discovered that this mutation reduces the immunogenicity of the spike protein; also, displacement of Asn with Tyr reduces protein compactness and significantly increases the stability of the spike protein and its affinity to ACE2. Moreover, following the N501Y mutation secondary structure and folding of the spike protein changed dramatically.

摘要

自严重急性呼吸系统综合症冠状病毒 2(SARS-CoV-2)出现以来,其基因组中已报告了大量突变。其中一些突变发生在非编码区域,不会影响病毒的病理生物学,而编码区域的突变则非常重要。可能发生突变并影响病毒功能的区域之一是刺突蛋白的受体结合域(RBD)。RBD 与血管紧张素转换酶 2(ACE2)相互作用,促进病毒进入宿主细胞。人们非常关注 RBD 突变,尤其是在英国/肯特、南非和巴西 SARS-CoV-2 谱系中观察到的 N501Y 取代。我们的小组利用计算生物学方法,如免疫信息学、蛋白质-蛋白质相互作用分析、分子动力学、自由能计算和三级结构分析,从分子水平揭示 N501Y 突变的后果。令人惊讶的是,我们发现该突变降低了刺突蛋白的免疫原性;此外,用 Tyr 取代 Asn 会降低蛋白质的紧凑性,并显著增加刺突蛋白的稳定性及其与 ACE2 的亲和力。此外,N501Y 突变后,刺突蛋白的二级结构和折叠发生了巨大变化。

相似文献

5
Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
Biochem Biophys Res Commun. 2021 Jan 1;534:374-380. doi: 10.1016/j.bbrc.2020.11.075. Epub 2020 Nov 28.
7
Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
Biochem Biophys Res Commun. 2021 Jan 29;538:97-103. doi: 10.1016/j.bbrc.2021.01.035. Epub 2021 Feb 15.
9
Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective.
Biochem Biophys Res Commun. 2021 Jul 12;562:89-93. doi: 10.1016/j.bbrc.2021.05.058. Epub 2021 May 21.
10
Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
Comput Biol Chem. 2022 Feb;96:107613. doi: 10.1016/j.compbiolchem.2021.107613. Epub 2021 Dec 1.

引用本文的文献

1
Association of RBD mutations with COVID-19 disease severity in the Iranian population.
Virus Genes. 2025 Jun 26. doi: 10.1007/s11262-025-02168-w.
2
Engineering Folic Acid-Modified Nanoparticles to Enhance Letrozole's Anticancer Action.
Macromol Biosci. 2025 Jul;25(7):e2400558. doi: 10.1002/mabi.202400558. Epub 2025 Apr 18.
3
Research progress of spike protein mutation of SARS-CoV-2 mutant strain and antibody development.
Front Immunol. 2024 Nov 18;15:1407149. doi: 10.3389/fimmu.2024.1407149. eCollection 2024.
5
Identification of conserved linear epitopes in the SARS-CoV-2 receptor-binding region using monoclonal antibodies.
Heliyon. 2023 Jun;9(6):e16847. doi: 10.1016/j.heliyon.2023.e16847. Epub 2023 Jun 3.
6
Structural evolution of Delta lineage of SARS-CoV-2.
Int J Biol Macromol. 2023 Jan 31;226:1116-1140. doi: 10.1016/j.ijbiomac.2022.11.227. Epub 2022 Nov 24.
7
Lethargy and quadraparesis as initial manifestations of covid-19 child: Case report.
Ann Med Surg (Lond). 2022 Dec;84:104911. doi: 10.1016/j.amsu.2022.104911. Epub 2022 Nov 17.

本文引用的文献

1
The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.
Nature. 2022 Feb;602(7896):294-299. doi: 10.1038/s41586-021-04245-0. Epub 2021 Nov 24.
2
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity.
Science. 2021 Aug 6;373(6555). doi: 10.1126/science.abi6226. Epub 2021 Jun 24.
3
CD44 polymorphisms and its variants, as an inconsistent marker in cancer investigations.
Mutat Res Rev Mutat Res. 2021 Jan-Jun;787:108374. doi: 10.1016/j.mrrev.2021.108374. Epub 2021 Mar 26.
4
Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.
PLoS Biol. 2021 Apr 29;19(4):e3001237. doi: 10.1371/journal.pbio.3001237. eCollection 2021 Apr.
5
Potential SARS-CoV-2 vaccines: Concept, progress, and challenges.
Int Immunopharmacol. 2021 Aug;97:107622. doi: 10.1016/j.intimp.2021.107622. Epub 2021 Mar 29.
8
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
Cell. 2021 Apr 29;184(9):2384-2393.e12. doi: 10.1016/j.cell.2021.03.036. Epub 2021 Mar 20.
9
SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera.
Cell Host Microbe. 2021 Apr 14;29(4):522-528.e2. doi: 10.1016/j.chom.2021.03.008. Epub 2021 Mar 20.
10
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.
Cell. 2021 Apr 15;184(8):2201-2211.e7. doi: 10.1016/j.cell.2021.02.033. Epub 2021 Feb 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验